1. Home
  2. PHAR vs SPTN Comparison

PHAR vs SPTN Comparison

Compare PHAR & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • SPTN
  • Stock Information
  • Founded
  • PHAR 1988
  • SPTN 1917
  • Country
  • PHAR Netherlands
  • SPTN United States
  • Employees
  • PHAR N/A
  • SPTN 17000
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • PHAR Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • PHAR Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • PHAR 618.3M
  • SPTN 630.9M
  • IPO Year
  • PHAR N/A
  • SPTN N/A
  • Fundamental
  • Price
  • PHAR $8.74
  • SPTN $18.55
  • Analyst Decision
  • PHAR Strong Buy
  • SPTN Hold
  • Analyst Count
  • PHAR 3
  • SPTN 1
  • Target Price
  • PHAR $27.00
  • SPTN $20.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • SPTN 248.1K
  • Earning Date
  • PHAR 03-13-2025
  • SPTN 02-12-2025
  • Dividend Yield
  • PHAR N/A
  • SPTN 4.71%
  • EPS Growth
  • PHAR N/A
  • SPTN 9.92
  • EPS
  • PHAR N/A
  • SPTN 1.33
  • Revenue
  • PHAR $285,745,000.00
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • PHAR $20.08
  • SPTN N/A
  • Revenue Next Year
  • PHAR $9.22
  • SPTN $2.15
  • P/E Ratio
  • PHAR N/A
  • SPTN $14.06
  • Revenue Growth
  • PHAR 30.64
  • SPTN N/A
  • 52 Week Low
  • PHAR $6.65
  • SPTN $17.30
  • 52 Week High
  • PHAR $13.20
  • SPTN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • SPTN 56.59
  • Support Level
  • PHAR $7.95
  • SPTN $17.77
  • Resistance Level
  • PHAR $9.35
  • SPTN $18.66
  • Average True Range (ATR)
  • PHAR 0.52
  • SPTN 0.40
  • MACD
  • PHAR -0.16
  • SPTN 0.11
  • Stochastic Oscillator
  • PHAR 22.76
  • SPTN 96.19

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: